Christian zu Jeddeloh
Impact Venture Capital Investor at Norrsken VC- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
-
Deutsch Native or bilingual proficiency
-
Englisch Full professional proficiency
-
Spanisch Professional working proficiency
-
Schwedisch Limited working proficiency
Topline Score
Bio
Experience
-
Norrsken VC
-
Sweden
-
Venture Capital and Private Equity Principals
-
1 - 100 Employee
-
Impact Venture Capital Investor
-
Oct 2022 - Present
Norrsken VC is an early-stage investor in startups which are solving the world's greatest challenges while building massive businesses. Supporting impact entrepreneurs at the Seed/Series A stages. Norrsken VC is an early-stage investor in startups which are solving the world's greatest challenges while building massive businesses. Supporting impact entrepreneurs at the Seed/Series A stages.
-
-
-
IntroSpect Digital Therapeutics
-
Biotechnology
-
Board Observer
-
Mar 2022 - Jul 2022
Introspect develops digital therapeutics to work in combination with atai's therapeutic interventions. Introspect develops digital therapeutics to work in combination with atai's therapeutic interventions.
-
-
-
Kures
-
Pharmaceutical Manufacturing
-
Board Observer
-
May 2021 - Jul 2022
Kures is a clinical-stage biopharmaceutical company developing novel MOR agonists. Kures is a clinical-stage biopharmaceutical company developing novel MOR agonists.
-
-
-
Psyber
-
United States
-
Mental Health Care
-
1 - 100 Employee
-
Board Observer
-
May 2021 - Jul 2022
Psyber develops a BCI-enabled digital therapeutic. Psyber develops a BCI-enabled digital therapeutic.
-
-
-
atai Life Sciences
-
Germany
-
Biotechnology Research
-
1 - 100 Employee
-
Investments & Venture Management
-
Feb 2021 - Jul 2022
atai Life Sciences is a German-based, internationally active biotech company investing in and acquiring promising therapeutics redefining how the world approaches, prevents, and heals mental health disorders. atai Life Sciences is a German-based, internationally active biotech company investing in and acquiring promising therapeutics redefining how the world approaches, prevents, and heals mental health disorders.
-
-
-
Gain.pro
-
Netherlands
-
Venture Capital and Private Equity Principals
-
100 - 200 Employee
-
Private Equity Research
-
Aug 2020 - Dec 2020
Financial and commercial analyses of private companies and industries Financial and commercial analyses of private companies and industries
-
-
-
UBS
-
Switzerland
-
Financial Services
-
700 & Above Employee
-
Sales & Trading
-
Jul 2020 - Aug 2020
Rotations in Equities Trading and HY Credit Trading Rotations in Equities Trading and HY Credit Trading
-
-
-
Commerzbank AG
-
Germany
-
Banking
-
700 & Above Employee
-
Mergers & Acquisitions
-
Jun 2019 - Aug 2019
Corporate Mergers & Acquisitions Corporate Mergers & Acquisitions
-
-
-
Deutsche Bank
-
Germany
-
Financial Services
-
700 & Above Employee
-
Asset Management
-
Jun 2018 - Sep 2018
Multi Asset Portfolio Management Multi Asset Portfolio Management
-
-
Education
-
Frankfurt School of Finance & Management
Bachelor of Science, Finance -
Harvard University
Visiting Undergraduate Student, Economics and Computer Science -
MIT Sloan School of Management
Cross-registration during exchange semester, Advanced Corporate Finance -
Tecnológico de Monterrey
Visiting Undergraduate Student, Finance -
Liebfrauenschule Oldenburg
Abitur